3rd Annual Pharma & Biotech Business Intelligence Summit September 18-19 in Princeton, N.J. Examines CI As Key to Strategic Decision Support

NEW YORK, Aug. 26, 2003 -- With pharma and biotech firms facing ever-mounting competitive pressures -- including that brought on by the rapidly expanding biogenerics market -- competitive intelligence is becoming increasing paramount throughout the industry. Industry leaders will be gathering at the 3rd Annual Pharma & Biotech Business Intelligence Summit, September 18-19 in Princeton, N.J.

Part of the evolution of competitive intelligence is its increased role and influence throughout all areas of pharma and biotech organizations. As the reach of CI has grown, however, it has concurrently become more important to align CI with the business' processes and objectives.

This year's summit -- chaired by Clifford Kalb, Senior Director of Strategic Business Analysis at Merck and Past President of the Pharmaceutical Business Intelligence & Research Group (PBIRG) -- will focus on the developing role of business intelligence as the key to strategic decision support. The company chair is held by Fletcher/CSI, who will also be giving a presentation on "Understanding A Company's Launch Strategy," which takes an objective look at modeling tools and techniques used to predict and define a company's potential launch initiative and how successful and meaningful these tools are in addressing a company's own market, sales and pipeline initiatives.

Industry leaders to appear include Jonas Pedersen, Director of Competitive Intelligence for Amgen; Monika Giese, VP of Business Intelligence & Analysis at F. Hoffman LaRoche; Mark R. Little, VP of Business Intelligence for Covance; Corlalie Hughes, CI Manager, Eli Lilly & Co.; Daniel Pascheles, VP & Head of Corporate Competitive Intelligence for Aventis Pharma; Neil Mahoney, former VP of Competitive Intelligence at Pharmacia and Novartis; Kathryn M. Jones, Assistant VP Business Performance Metrics at Wyeth Pharmaceuticals; Renee F. Pierson, Group Director of Business Analytics & Assessments, Ortho- McNeil Pharmaceutical; Sue Ward, Manager of Business Intelligence at Pfizer, and many more.

Sponsors include Mayer, Brown, Rowe & Maw; Fletcher/CSI; Proactive Worldwide; and Dendrite. Exhibits scheduled for this year's event include Citeline, Cognos, and the Dunn Group.

To register, please call 1-888-666-8514, e-mail: info@srinstitute.com, or log onto: http://www.srinstitute.com/cm416. PLEASE MENTION PRIORITY CODE DPR000664 WHEN REGISTERING. For conference information or sponsoring and exhibiting opportunities contact Christopher Dauer at cdauer@srinstitute.com or 212-967-0095 ext. 254, or Michelle Castonguay at mcastonguay@srinstitute.com at 212-967-0095 ext. 269, or visit http://www.srinstitute.com/cm416.

SOURCE Strategic Research Institute

Web Site: http://www.srinstitute.com